Histaminergic H3-Heteroreceptors as a Potential Mediator of Betahistine-Induced Increase in Cochlear Blood Flow

Audiol Neurootol. 2015;20(5):283-93. doi: 10.1159/000368293. Epub 2015 Jun 27.

Abstract

Objective: Betahistine is a histamine-like drug that is considered beneficial in Ménière's disease by increasing cochlear blood flow. Acting as an agonist at the histamine H1-receptor and as an inverse agonist at the H3-receptor, these receptors as well as the adrenergic α2-receptor were investigated for betahistine effects on cochlear blood flow.

Materials and methods: A total of 54 Dunkin-Hartley guinea pigs were randomly assigned to one of nine groups treated with a selection of H1-, H3- or α2-selective agonists and antagonists together with betahistine. Cochlear blood flow and mean arterial pressure were recorded for 3 min before and 15 min after infusion.

Results: Blockage of the H3- or α2-receptors caused a suppression of betahistine-mediated typical changes in cochlear blood flow or blood pressure. Activation of H3-receptors caused a drop in cochlear blood flow and blood pressure. H1-receptors showed no involvement in betahistine-mediated changes of cochlear blood flow.

Conclusion: Betahistine most likely affects cochlear blood flow through histaminergic H3-heteroreceptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Betahistine / pharmacology*
  • Cochlea / blood supply*
  • Cochlea / drug effects
  • Cochlea / metabolism
  • Female
  • Guinea Pigs
  • Histamine Agonists / pharmacology*
  • Histamine Antagonists / pharmacology*
  • Receptors, Histamine H3 / metabolism*
  • Regional Blood Flow / drug effects*
  • Regional Blood Flow / physiology

Substances

  • Histamine Agonists
  • Histamine Antagonists
  • Receptors, Histamine H3
  • Betahistine